Division of Medicinal Chemistry, Faculty of Sciences, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, De Boelelaan 1108, Amsterdam 1081 HZ, The Netherlands; These authors contributed equally.
iHuman Institute, ShanghaiTech University, 393 Hua Xia Zhong Road, Shanghai 201210, China; These authors contributed equally.
Trends Biochem Sci. 2017 Dec;42(12):946-960. doi: 10.1016/j.tibs.2017.10.003. Epub 2017 Nov 11.
The secretin-like class B family of G protein-coupled receptors (GPCRs) are key players in hormonal homeostasis. Recent structures of various receptors in complex with a variety of orthosteric and allosteric ligands provide fundamental new insights into the function and mechanism of class B GPCRs, including: (i) ligand-induced changes in the relative orientation of the extracellular and transmembrane receptor domains; (ii) intramolecular interaction networks that stabilize conformational changes to accommodate intracellular G protein binding; and (iii) allosteric modulation of receptor activation. This review provides a comprehensive analysis of the structural, biochemical, and pharmacological data on class B GPCRs for understanding ligand-receptor interaction and modulation mechanisms and assessing the potential implications for drug discovery for the secretin-like GPCR family.
G 蛋白偶联受体(GPCR)家族的分泌素样 B 类是激素动态平衡的关键参与者。各种受体与各种正位和变构配体结合的最近结构为 B 类 GPCR 的功能和机制提供了基本的新见解,包括:(i)配体诱导的细胞外和跨膜受体结构域相对取向的变化;(ii)稳定构象变化以适应细胞内 G 蛋白结合的分子内相互作用网络;和(iii)变构调节受体激活。本综述全面分析了 B 类 GPCR 的结构、生化和药理学数据,以了解配体-受体相互作用和调节机制,并评估其对分泌素样 GPCR 家族药物发现的潜在影响。